Procter & Gamble Health Limited informed that the Board of Directors of the Company at its meeting held on May 5, 2022, inter alia, has recommended an Interim Dividend for the Financial Year 2021-22 of INR 41 per Equity Share (Face Value of INR 10/- each). The dividend shall be paid on or before May 31, 2022. As informed earlier in letter dated April 28, 2022, the record date for the purpose of eligibility for payment of said Interim Dividend shall be May 13, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4,749 INR | -1.27% | +0.52% | -3.98% |
May. 03 | Procter & Gamble Health's Profit Declines in Fiscal Q3 | MT |
May. 02 | Procter & Gamble Health Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024 | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-3.98% | 945M | |
+19.98% | 43.48B | |
+20.67% | 22.65B | |
+14.56% | 14.73B | |
+14.32% | 13.79B | |
+44.72% | 12.04B | |
-8.37% | 7.08B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+11.90% | 5.47B |
- Stock Market
- Equities
- 500126 Stock
- News Procter & Gamble Health Limited
- Procter & Gamble Health Limited Recommends Interim Dividend for the Financial Year 2021-22, payable on or before May 31, 2022